Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme

HealthTech approach

HealthTech approach

Advice programme

Area of interest

Showing 451 to 475 of 2559

TitleReference numberPublishedLast updated
Aortic valve reconstruction with glutaraldehyde-treated autologous pericardium for aortic valve diseaseHTG689
Venous thromboembolic diseases: diagnosis, management and thrombophilia testingNG158
Afamelanotide for treating erythropoietic protoporphyriaHST27
Selpercatinib for untreated RET fusion-positive advanced non-small-cell lung cancerTA911
KardiaMobile for detecting atrial fibrillationHTG606
Semaglutide for managing overweight and obesity in young people aged 12 to 17 years (terminated appraisal)TA910
Alcohol-use disorders: diagnosis and managementQS11
Artificial intelligence (AI)-derived computer-aided detection (CAD) software for detecting and measuring lung nodules in CT scan imagesHTG687
Irreversible electroporation for treating prostate cancerHTG688
Olaparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube or peritoneal cancer after 2 or more courses of platinum-based chemotherapyTA908
Rimegepant for preventing migraineTA906
Oesophago-gastric cancer: assessment and management in adultsNG83
Depression in adultsQS8
Botulinum toxin type A injections into the urethral sphincter for idiopathic chronic non-obstructive urinary retentionHTG685
Radiofrequency denervation for osteoarthritic knee painHTG686
Deucravacitinib for treating moderate to severe plaque psoriasisTA907
Endoscopic ultrasound-guided gallbladder drainage for acute cholecystitis when surgery is not an optionHTG683
Minimally invasive fusionless posterior-approach surgery to correct idiopathic scoliosis in children and young peopleHTG684
Pembrolizumab with lenvatinib for previously treated advanced or recurrent endometrial cancerTA904
Upadacitinib for previously treated moderately to severely active Crohn's diseaseTA905
Dapagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fractionTA902
Darolutamide with androgen deprivation therapy and docetaxel for treating hormone-sensitive metastatic prostate cancerTA903
MiraQ cardiac TTFM with high-frequency probe for assessing graft flow during coronary artery bypass graft surgeryMIB323
Cemiplimab for treating recurrent or metastatic cervical cancer (terminated appraisal)TA901
Dabrafenib plus trametinib for treating BRAF V600 mutation-positive advanced non-small-cell lung cancerTA898

Results per page

  1. 10
  2. 25
  3. 50
  4. All